DNA-based immunization has initiated a new era of vaccine research. One of
the main goals of gene vaccine development is the control of the levels of
expression in vivo for efficient immunization. Modifying the vector to modu
late expression or immunogenicity is of critical importance for the improve
ment of DNA vaccines. The most frequently used vectors for genetic immuniza
tion are plasmids, In this article, we review some of the main elements rel
evant to their design such as strong promoter/enhancer region, introns, gen
es encoding antigens of interest from the pathogen (how to choose and modif
y them), polyadenylation termination sequence, origin of replication for pl
asmid production in Escherichia coli, antibiotic resistance gene as selecta
ble marker, convenient cloning sites, and the presence of immunostimulatory
sequences (ISS) that can be added to the plasmid to enhance adjuvanticity
and to activate the immune system. In this review, the specific modificatio
ns that can increase overall expression as well as the potential of DNA-bas
ed vaccination are also discussed.